Cite
HARVARD Citation
Switzer, B. et al. (2021). Clinical and immunologic implications of COVID-19 in patients with melanoma and renal cell carcinoma receiving immune checkpoint inhibitors. Journal for immunotherapy of cancer. 9 (7), p. . [Online].